INNOVATION PHARMACEUTICALS INC. Retained Earnings
INNOVATION PHARMACEUTICALS INC. had Retained Earnings of -$126.20 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-20
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$126.20M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$125.33M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$124.64M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$123.95M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-09-30 | -$126.20M 10-Q · filed 2023-11-20 |
| 2023-06-30 | -$125.33M 10-Q · filed 2023-11-20 |
| 2023-03-31 | -$124.64M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$123.95M 10-Q · filed 2023-02-15 |
| 2022-09-30 | -$123.58M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$122.16M 10-K · filed 2023-09-28 |
| 2022-03-31 | -$120.53M 10-Q · filed 2022-05-13 |
| 2021-12-31 | -$119.05M 10-Q · filed 2022-02-14 |
| 2021-09-30 | -$117.17M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$115.12M 10-K · filed 2022-09-28 |
| 2021-03-31 | -$112.55M 10-Q · filed 2021-05-13 |
| 2020-12-31 | -$108.59M 10-Q · filed 2021-02-22 |
| 2020-09-30 | -$102.42M 10-Q · filed 2020-11-16 |
| 2020-06-30 | -$101.24M 10-K · filed 2021-09-27 |
| 2020-03-31 | -$99.77M 10-Q · filed 2020-05-14 |
| 2019-12-31 | -$98.77M 10-Q · filed 2020-02-13 |
| 2019-09-30 | -$96.15M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$94.60M 10-K · filed 2020-09-14 |
| 2019-03-31 | -$93.08M 10-Q · filed 2019-05-10 |
| 2018-12-31 | -$91.94M 10-Q · filed 2019-02-08 |
| 2018-09-30 | -$87.97M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$85.92M 10-K · filed 2019-09-30 |
| 2018-03-31 | -$81.05M 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$78.61M 10-Q · filed 2018-02-07 |
| 2017-09-30 | -$74.09M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$69.55M 10-K · filed 2018-09-11 |
| 2017-03-31 | -$64.31M 10-Q · filed 2017-05-09 |
| 2016-12-31 | -$60.40M 10-Q · filed 2017-02-09 |
| 2016-09-30 | -$57.05M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$54.02M 10-K · filed 2017-09-11 |
| 2016-03-31 | -$50.77M 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$47.06M 10-Q · filed 2016-02-08 |
| 2015-09-30 | -$43.74M 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$41.16M 10-K · filed 2016-09-13 |
| 2015-03-31 | -$38.06M 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$35.17M 10-Q · filed 2015-02-09 |
| 2014-09-30 | -$32.41M 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$28.02M 10-K · filed 2015-09-11 |
| 2013-06-30 | -$19.77M 10-K · filed 2014-09-15 |